EOSC4Cancer A European-wide foundation to accelerate Data-driven Cancer Research
- Coordinator
- Barcelona Supercomputing Center Centro Nacional De Supercomputacion, Spain
- Runs
- 1 September 2022 to 31 May 2025
- Status
- Finished
- EU funding
- €7.8m
- Total cost
- €7.8m
- Partners
- 36 organisations in 13 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101058427
What the project is doing
In the project's own words, from its summary on CORDIS.
Cancer complex nature requires integration of advanced research data across national boundaries to enable progress. Indeed, the Horizon Europe mission board for cancer has identified access to data, knowledge and digital services - accessible across the European Research Area through federated infrastructures - as a key enabling condition for success. The better we organise cancer data across Europe, the better and faster we can bring the fruits of new biological and technical innovations to the benefit of EU citizens/patients.
EOSC4Cancer will make cancer genomics, imaging, medical, clinical, environmental and socio-economics data accessible, using and enhancing existing federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR cancer data across borders, and it will offer them via community-driven analysis environments. EOSC4Cancer provision of well curated datasets will be essential for advanced analytics and computational methods to be reproducible and robust, including machine learning and artificial intelligence approaches.
EOSC4Cancer use-cases will cover the patient journey from cancer prevention to diagnosis to treatment, laying the foundation of data trajectories and workflows for future cancer mission projects. EOSC4Cancer brings together a comprehensive consortium of cancer research centres, research infrastructures, leading research groups, hospitals and supercomputing centres from 14 European countries. To make the developments sustainable, these will be offered as part of the research infrastructures partners services portfolio, in connection with the EOSC ecosystem and to serve the European Cancer Mission, which will be possible via the engagement with large international coalitions, e.g.
ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action and patients/survivors associations.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Barcelona Supercomputing Center Centro Nacional De Supercomputacion | Barcelona | Spain | Coordinator |
| Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric) | Graz | Austria | Participant |
| Cancer Patients Europe | Bruxelles / Brussel | Belgium | Participant |
| European Cancer Patient Coalition | Bruxelles / Brussel | Belgium | Participant |
| Masarykova univerzita | Brno | Czechia | Participant |
| Univerzita Palackeho V Olomouci | Olomouc | Czechia | Participant |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Third party |
| Albert-Ludwigs-Universitaet Freiburg | Freiburg | Germany | Participant |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Participant |
| Empirica Gesellschaft Fur Kommunikations Und Technologieforschung Mbh | Bonn | Germany | Participant |
| European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric) | Berlin | Germany | Participant |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| Infrafrontier Eric | Neuherberg | Germany | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Participant |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Participant |
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Participant |
| Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio) | Barcelona | Spain | Participant |
| Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii | Madrid | Spain | Participant |
| Csc-Tieteen Tietotekniikan Keskus Oy | Espoo | Finland | Third party |
| Euro-Bioimaging Eric | Turku | Finland | Participant |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Ecrin European Clinical Research Infrastructure Network | Paris | France | Participant |
| Universite De Bordeaux | Bordeaux | France | Participant |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Participant |
| Universita Degli Studi Di Torino | Torino | Italy | Third party |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Participant |
| Eatris Eric | Amsterdam | Netherlands | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Third party |
| Stichting Health-Ri | Utrecht | Netherlands | Third party |
| Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | Amsterdam | Netherlands | Participant |
| Stichting Lygature | Utrecht | Netherlands | Participant |
| Universitetet I Oslo | Oslo | Norway | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Instruct-Eric | Oxford | United Kingdom | Participant |
| The University of Manchester | Manchester | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI